{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T17:14:58Z","timestamp":1774804498878,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-Sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bcp.2021.114562","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T20:01:21Z","timestamp":1618948881000},"page":"114562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells"],"prefix":"10.1016","volume":"188","author":[{"given":"Xiao-hong","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114562_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570161117666190502103733","article-title":"Microvascular complications of type 2 diabetes mellitus","volume":"18","author":"Faselis","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114562_b0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-physiol-020911-153333","article-title":"Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney","volume":"74","author":"Vallon","year":"2012","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bcp.2021.114562_b0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","article-title":"A glimpse of various pathogenetic mechanisms of diabetic nephropathy","volume":"6","author":"Kanwar","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114562_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","article-title":"Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention","volume":"15","author":"Liu","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2021.114562_b0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bcp.2014.09.002","article-title":"Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway","volume":"92","author":"Bai","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114562_b0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ki.5002180","article-title":"Phenotypic transitions and fibrosis in diabetic nephropathy","volume":"71","author":"Simonson","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2021.114562_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00441-011-1227-1","article-title":"The role of EMT in renal fibrosis","volume":"347","author":"Carew","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2021.114562_b0040","doi-asserted-by":"crossref","unstructured":"X.Y. Bai, J. Geng, Z.M. Zhou, J.W. Tian, X. Li, MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy, Sci. Rep.-UK 6 (2016).","DOI":"10.1038\/srep20475"},{"key":"10.1016\/j.bcp.2021.114562_b0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2021.114562_b0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","article-title":"Perilous journey: a tour of the ubiquitin-proteasome system","volume":"24","author":"Kleiger","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2021.114562_b0055","first-page":"1","article-title":"The role of ubiquitination and sumoylation in diabetic nephropathy","volume":"2014","author":"Gao","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bcp.2021.114562_b0060","first-page":"1","article-title":"The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro","volume":"2014","author":"Huang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bcp.2021.114562_b0065","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00018-015-1851-0","article-title":"La FAM fatale: USP9X in development and disease","volume":"72","author":"Murtaza","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2021.114562_b0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrm3143","article-title":"Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death","volume":"12","author":"Vucic","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114562_b0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2008.10.051","article-title":"FAM\/USP9x, a deubiquitinating enzyme essential for TGF beta signaling, controls Smad4 monoubiquitination","volume":"136","author":"Dupont","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2021.114562_b0080","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1074\/jbc.M112.430066","article-title":"Deubiquitinase FAM\/USP9X Interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation","volume":"288","author":"Xie","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114562_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cardiores.2003.11.013","article-title":"Gap junctions and the connexin protein family","volume":"62","author":"Sohl","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2021.114562_b0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2015.09.030","article-title":"The renal connexome and possible roles of connexins in kidney diseases","volume":"67","author":"Sala","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bcp.2021.114562_b0095","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1006\/jmcc.1999.0937","article-title":"Chamber-related differences in connexin expression in the human heart","volume":"31","author":"Vozzi","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2021.114562_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pharmthera.2015.06.005","article-title":"Connexin 43 is an emerging therapeutic target in ischemia\/reperfusion injury, cardioprotection and neuroprotection","volume":"153","author":"Schulz","year":"2015","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.bcp.2021.114562_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/1478-811X-11-38","article-title":"Connexin43 mediates NF-kappa B signalling activation induced by high glucose in GMCs: involvement of c-Src","volume":"11","author":"Xie","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bcp.2021.114562_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2016.11.015","article-title":"Connexin43 regulates high glucose-induced expression of fibronectin, ICAM-1 and TGF-beta 1 via Nrf2\/ARE pathway in glomerular mesangial cells","volume":"102","author":"Chen","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2021.114562_b0115","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1042\/CS20200171","article-title":"Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1 alpha signaling pathway","volume":"134","author":"Sun","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bcp.2021.114562_b0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.yexcr.2014.07.019","article-title":"RhoA\/rho kinase signaling reduces connexin43 expression in high glucose-treated glomerular mesangial cells with zonula occludens-1 involvement","volume":"327","author":"Xie","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2021.114562_b0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114562_b0130","doi-asserted-by":"crossref","first-page":"25207","DOI":"10.1074\/jbc.275.33.25207","article-title":"Regulation of connexin degradation as a mechanism to increase gap junction assembly and function","volume":"275","author":"Musil","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114562_b0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000092561","article-title":"Role of connexin43-interacting proteins at gap junctions","volume":"42","author":"Giepmans","year":"2006","journal-title":"Adv. Cardiol."},{"key":"10.1016\/j.bcp.2021.114562_b0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/BJ20102059","article-title":"Ubiquitin-mediated internalization of connexin43 is independent of the canonical endocytic tyrosine-sorting signal","volume":"437","author":"Catarino","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2021.114562_b0145","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI111523","article-title":"Structural-functional relationships in diabetic nephropathy","volume":"74","author":"Mauer","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2021.114562_b0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00041552-200105000-00004","article-title":"Renal fibrosis: an update","volume":"10","author":"Zeisberg","year":"2001","journal-title":"Curr. Opin. Nephrol. Hy."},{"key":"10.1016\/j.bcp.2021.114562_b0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1083\/jcb.130.2.393","article-title":"Identification and characterization of a fibroblast marker: FSP1","volume":"130","author":"Strutz","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114562_b0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ndt\/15.suppl_6.44","article-title":"Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo","volume":"15","author":"Okada","year":"2000","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.bcp.2021.114562_b0165","first-page":"131","article-title":"The role of TGF-beta and epithelial-to mesenchymal transition in diabetic nephropathy","volume":"22","author":"Hills","year":"2011","journal-title":"Cytokine Growth F R"},{"key":"10.1016\/j.bcp.2021.114562_b0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00125-011-2409-9","article-title":"TGF beta modulates cell-to-cell communication in early epithelial-to-mesenchymal transition","volume":"55","author":"Hills","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2021.114562_b0175","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2015010006","article-title":"Failed tubule recovery, AKI-CKD transition, and kidney disease progression","volume":"26","author":"Venkatachalam","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2021.114562_b0180","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","article-title":"The logic of the 26S proteasome","volume":"169","author":"Collins","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2021.114562_b0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41581-019-0148-1","article-title":"The ubiquitin-proteasome system in kidney physiology and disease","volume":"15","author":"Meyer-Schwesinger","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2021.114562_b0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrs.2017.03.024","article-title":"Hidden targets of ubiquitin proteasome system: to prevent diabetic nephropathy","volume":"120","author":"Goru","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2021.114562_b0195","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bcp.2011.07.066","article-title":"Linear ubiquitination in NF-kappaB signaling and inflammation: what we do understand and what we do not","volume":"82","author":"Verhelst","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114562_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/918396","article-title":"MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy","volume":"2014","author":"Gao","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bcp.2021.114562_b0205","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.2174\/1381612811319220013","article-title":"Deubiquitinating enzymes as therapeutic targets in cancer","volume":"19","author":"Lim","year":"2013","journal-title":"Curr. Pharm. Design."},{"key":"10.1016\/j.bcp.2021.114562_b0210","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00018-015-2129-2","article-title":"Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint","volume":"73","author":"Lim","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2021.114562_b0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/en.2014-1381","article-title":"AGEs-RAGE system down-regulates Sirt1 through the ubiquitin- proteasome pathway to promote FN and TGF-beta 1 expression in male rat glomerular mesangial cells","volume":"156","author":"Huang","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2021.114562_b0220","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajhg.2014.02.004","article-title":"Mutations in USP9X are associated with X-linked intellectual disability and disrupt neuronal cell migration and growth","volume":"94","author":"Homan","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2021.114562_b0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cub.2015.11.050","article-title":"USP9X controls EGFR fate by deubiquitinating the endocytic adaptor eps15","volume":"26","author":"Savio","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bcp.2021.114562_b0230","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1073\/pnas.1221925110","article-title":"Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2021.114562_b0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00125-014-3427-1","article-title":"Mind the gap: connexins and cell-cell communication in the diabetic kidney","volume":"58","author":"Hills","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2021.114562_b0240","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev.cellbio.19.111301.144309","article-title":"Connexins and cell signaling in development and disease","volume":"20","author":"Wei","year":"2004","journal-title":"Annu. Rev. Cell"},{"key":"10.1016\/j.bcp.2021.114562_b0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0928-4257(02)00012-8","article-title":"Formation of the gap junction nexus: binding partners for connexins","volume":"96","author":"Duffy","year":"2002","journal-title":"J. Physiol.-Paris"},{"issue":"2","key":"10.1016\/j.bcp.2021.114562_b0250","first-page":"133","article-title":"Regulation of connexins by the ubiquitin system: Implications for intercellular communication and cancer","volume":"1865","author":"Leithe","year":"2016","journal-title":"BBA-Rev. Cancer"},{"key":"10.1016\/j.bcp.2021.114562_b0255","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1074\/jbc.M709288200","article-title":"A novel connexin43-interacting protein, CIP75, which belongs to the UbL-UBA protein family, regulates the turnover of connexin43","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114562_b0260","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1242\/jcs.03149","article-title":"Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation- modulated process","volume":"119","author":"Leykauf","year":"2006","journal-title":"J. Cell Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:27:32Z","timestamp":1757770052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":52,"alternative-id":["S0006295221001581"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114562","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114562"}}